Pterygium Drug - Global and China Top Players Market Share and Ranking 2023
According to Market IntelliX Research, the global market for Pterygium Drug should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Pterygium Drug market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Pterygium Drug market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Progressive Pterygium grew percent to account for percent of the total market sales, and Atrophic Pterygium grew percent.
Pterygium is a common ocular surface lesion that begins in the limbal conjunctiva within the palpebral fissure and progresses to the cornea. It is named after the Greek word pterygos, which means "wing". The lesion occurs more frequently at the nasal limbus than the temporal with a characteristic wing-like appearance. UV exposure is strongly linked to the occurrence of pterygia. Individuals having a history of elevated UV exposure and those living closer to the equator have a higher incidence (outdoor work). According to certain research, males have a somewhat higher incidence than females, which could simply be due to a higher rate of UV exposure.
This report studies and analyses global Pterygium Drug status and future trends, helps the client to determine the Pterygium Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pterygium Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Pterygium Drug market size, history data 2019-2024, and forecast data 2024 -2030, (US$ million) & (K Units)
(2) Global Pterygium Drug sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(3) China Pterygium Drug sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(4) Global Pterygium Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Pterygium Drug key producing regions, capacity, production, and year over year growth
(6) Pterygium Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Johnson & Johnson Services, Inc
Novartis AG
Akorn Operating Company LLC
Bausch & Lomb Incorporated
AbbVie Inc
Prestige Consumer Healthcare Inc
Spectra Vision Care
Théa Laboratories
Wellona Pharma
SAGER PHARMA
Maya Biotech Private Limited
EYERIS VISIONCARE Pvt。Ltd
Sylentis
Bayer AG
Zydus Group
Amneal Pharmaceuticals LLC
OASIS Medical
Similasan Corporation
Alcon
Santen Pharmaceutical
Market segment by Type, covers
Artificial Tears
Steroid Eye Drops
Other
Market segment by Application, can be divided into
Progressive Pterygium
Atrophic Pterygium
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Pterygium Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Pterygium Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 3: China Pterygium Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 4: Global key producing regions of Pterygium Drug, percent & CAGR, 2019-2030
Chapter 5: Pterygium Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Pterygium Drug Definition
1.2 Global Pterygium Drug Market Size and Forecast
1.2.1 By Consumption Value, Global Pterygium Drug Market Size，2019-2030
1.2.2 By Sales Quantity, Global Pterygium Drug Market Size，2019-2030
1.2.3 Global Pterygium Drug Average Selling Price (ASP)，2019-2030
1.3 China Pterygium Drug Market Size and Forecast
1.3.1 By Consumption Value, China Pterygium Drug Market Size，2019-2030
1.3.2 By Sales Quantity, China Pterygium Drug Market Size，2019-2030
1.3.3 China Pterygium Drug Average Selling Price (ASP)， 2019-2030
1.4 Share of China Pterygium Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China Pterygium Drug Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Pterygium Drug Market Share in Global, 2019-2030
1.4.3 Pterygium Drug Market Size: China VS Global, 2019-2030
1.5 Pterygium Drug Market Dynamics
1.5.1 Pterygium Drug Market Drivers
1.5.2 Pterygium Drug Market Restraints
1.5.3 Pterygium Drug Industry Trends
1.5.4 Pterygium Drug Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Pterygium Drug, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Pterygium Drug, Global Market Share by Company, 2019-2024
2.3 Pterygium Drug Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Pterygium Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Pterygium Drug Concentration Ratio
2.6 Global Pterygium Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Pterygium Drug Manufacturers Product Type
2.8 Head Office and Pterygium Drug Production Site of Key Manufacturer
2.9 Pterygium Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Pterygium Drug, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Pterygium Drug, China Market Share by Company, 2019-2024
3.3 China Pterygium Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Pterygium Drug Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Pterygium Drug Capacity by Region
4.3 Global Pterygium Drug Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Pterygium Drug Production by Region, 2019-2030
4.5 Global Pterygium Drug Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Pterygium Drug Industry Chain
5.2 Pterygium Drug Upstream Analysis
5.2.1 Pterygium Drug Core Raw Materials
5.2.2 Main Manufacturers of Pterygium Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pterygium Drug Production Mode
5.6 Pterygium Drug Procurement Model
5.7 Pterygium Drug Industry Sales Model and Sales Channels
5.7.1 Pterygium Drug Sales Model
5.7.2 Pterygium Drug Typical Distributors
6 Sights by Type
6.1 Pterygium Drug Classification
6.1.1 Artificial Tears
6.1.2 Steroid Eye Drops
6.1.3 Other
6.2 By Type, Global Pterygium Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Pterygium Drug Consumption Value, 2019-2030
6.4 By Type, Global Pterygium Drug Sales Quantity, 2019-2030
6.5 By Type, Global Pterygium Drug Average Selling Price (ASP), 2019-2030
7 Sights by Application
7.1 Pterygium Drug Segment by Application
7.1.1 Progressive Pterygium
7.1.2 Atrophic Pterygium
7.2 By Application, Global Pterygium Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Pterygium Drug Consumption Value, 2019-2030
7.4 By Application, Global Pterygium Drug Sales Quantity, 2019-2030
7.5 By Application, Global Pterygium Drug Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Pterygium Drug Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Pterygium Drug Consumption Value, 2019-2030
8.3 By Region, Global Pterygium Drug Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Pterygium Drug & Forecasts, 2019-2030
8.4.2 By Country, North America Pterygium Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Pterygium Drug Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Pterygium Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Pterygium Drug Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Pterygium Drug Market Size Market Share
8.7 South America
8.7.1 South America Pterygium Drug Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Pterygium Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Pterygium Drug Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Pterygium Drug Consumption Value, 2019-2030
9.3 By Country, Global Pterygium Drug Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Pterygium Drug Market Size, 2019-2030
9.4.2 By Type, U.S. Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.4.3 By Application, U.S. Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.5 Europe
9.5.1 Europe Pterygium Drug Market Size, 2019-2030
9.5.2 By Type, Europe Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.5.3 By Application, Europe Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.6 China
9.6.1 China Pterygium Drug Market Size, 2019-2030
9.6.2 By Type, China Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.6.3 By Application, China Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.7 Japan
9.7.1 Japan Pterygium Drug Market Size, 2019-2030
9.7.2 By Type, Japan Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.7.3 By Application, Japan Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.8 South Korea
9.8.1 South Korea Pterygium Drug Market Size, 2019-2030
9.8.2 By Type, South Korea Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.8.3 By Application, South Korea Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Pterygium Drug Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.9.3 By Application, Southeast Asia Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.10 India
9.10.1 India Pterygium Drug Market Size, 2019-2030
9.10.2 By Type, India Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.10.3 By Application, India Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.11 Middle East & Africa
9.11.1 Middle East & Africa Pterygium Drug Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
9.11.3 By Application, Middle East & Africa Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
10 Manufacturers Profile
10.1 Johnson & Johnson Services, Inc
10.1.1 Johnson & Johnson Services, Inc Company Information, Head Office, Market Area, and Industry Position
10.1.2 Johnson & Johnson Services, Inc Pterygium Drug Models, Specifications, and Application
10.1.3 Johnson & Johnson Services, Inc Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Johnson & Johnson Services, Inc Company Profile and Main Business
10.1.5 Johnson & Johnson Services, Inc Recent Developments
10.2 Novartis AG
10.2.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.2.2 Novartis AG Pterygium Drug Models, Specifications, and Application
10.2.3 Novartis AG Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Novartis AG Company Profile and Main Business
10.2.5 Novartis AG Recent Developments
10.3 Akorn Operating Company LLC
10.3.1 Akorn Operating Company LLC Company Information, Head Office, Market Area, and Industry Position
10.3.2 Akorn Operating Company LLC Pterygium Drug Models, Specifications, and Application
10.3.3 Akorn Operating Company LLC Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Akorn Operating Company LLC Company Profile and Main Business
10.3.5 Akorn Operating Company LLC Recent Developments
10.4 Bausch & Lomb Incorporated
10.4.1 Bausch & Lomb Incorporated Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bausch & Lomb Incorporated Pterygium Drug Models, Specifications, and Application
10.4.3 Bausch & Lomb Incorporated Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Bausch & Lomb Incorporated Company Profile and Main Business
10.4.5 Bausch & Lomb Incorporated Recent Developments
10.5 AbbVie Inc
10.5.1 AbbVie Inc Company Information, Head Office, Market Area, and Industry Position
10.5.2 AbbVie Inc Pterygium Drug Models, Specifications, and Application
10.5.3 AbbVie Inc Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 AbbVie Inc Company Profile and Main Business
10.5.5 AbbVie Inc Recent Developments
10.6 Prestige Consumer Healthcare Inc
10.6.1 Prestige Consumer Healthcare Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Prestige Consumer Healthcare Inc Pterygium Drug Models, Specifications, and Application
10.6.3 Prestige Consumer Healthcare Inc Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Prestige Consumer Healthcare Inc Company Profile and Main Business
10.6.5 Prestige Consumer Healthcare Inc Recent Developments
10.7 Spectra Vision Care
10.7.1 Spectra Vision Care Company Information, Head Office, Market Area, and Industry Position
10.7.2 Spectra Vision Care Pterygium Drug Models, Specifications, and Application
10.7.3 Spectra Vision Care Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Spectra Vision Care Company Profile and Main Business
10.7.5 Spectra Vision Care Recent Developments
10.8 Théa Laboratories
10.8.1 Théa Laboratories Company Information, Head Office, Market Area, and Industry Position
10.8.2 Théa Laboratories Pterygium Drug Models, Specifications, and Application
10.8.3 Théa Laboratories Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Théa Laboratories Company Profile and Main Business
10.8.5 Théa Laboratories Recent Developments
10.9 Wellona Pharma
10.9.1 Wellona Pharma Company Information, Head Office, Market Area, and Industry Position
10.9.2 Wellona Pharma Pterygium Drug Models, Specifications, and Application
10.9.3 Wellona Pharma Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Wellona Pharma Company Profile and Main Business
10.9.5 Wellona Pharma Recent Developments
10.10 SAGER PHARMA
10.10.1 SAGER PHARMA Company Information, Head Office, Market Area, and Industry Position
10.10.2 SAGER PHARMA Pterygium Drug Models, Specifications, and Application
10.10.3 SAGER PHARMA Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 SAGER PHARMA Company Profile and Main Business
10.10.5 SAGER PHARMA Recent Developments
10.11 Maya Biotech Private Limited
10.11.1 Maya Biotech Private Limited Company Information, Head Office, Market Area, and Industry Position
10.11.2 Maya Biotech Private Limited Pterygium Drug Models, Specifications, and Application
10.11.3 Maya Biotech Private Limited Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Maya Biotech Private Limited Company Profile and Main Business
10.11.5 Maya Biotech Private Limited Recent Developments
10.12 EYERIS VISIONCARE Pvt。Ltd
10.12.1 EYERIS VISIONCARE Pvt。Ltd Company Information, Head Office, Market Area, and Industry Position
10.12.2 EYERIS VISIONCARE Pvt。Ltd Pterygium Drug Models, Specifications, and Application
10.12.3 EYERIS VISIONCARE Pvt。Ltd Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 EYERIS VISIONCARE Pvt。Ltd Company Profile and Main Business
10.12.5 EYERIS VISIONCARE Pvt。Ltd Recent Developments
10.13 Sylentis
10.13.1 Sylentis Company Information, Head Office, Market Area, and Industry Position
10.13.2 Sylentis Pterygium Drug Models, Specifications, and Application
10.13.3 Sylentis Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Sylentis Company Profile and Main Business
10.13.5 Sylentis Recent Developments
10.14 Bayer AG
10.14.1 Bayer AG Company Information, Head Office, Market Area, and Industry Position
10.14.2 Bayer AG Pterygium Drug Models, Specifications, and Application
10.14.3 Bayer AG Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Bayer AG Company Profile and Main Business
10.14.5 Bayer AG Recent Developments
10.15 Zydus Group
10.15.1 Zydus Group Company Information, Head Office, Market Area, and Industry Position
10.15.2 Zydus Group Pterygium Drug Models, Specifications, and Application
10.15.3 Zydus Group Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Zydus Group Company Profile and Main Business
10.15.5 Zydus Group Recent Developments
10.16 Amneal Pharmaceuticals LLC
10.16.1 Amneal Pharmaceuticals LLC Company Information, Head Office, Market Area, and Industry Position
10.16.2 Amneal Pharmaceuticals LLC Pterygium Drug Models, Specifications, and Application
10.16.3 Amneal Pharmaceuticals LLC Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.16.4 Amneal Pharmaceuticals LLC Company Profile and Main Business
10.16.5 Amneal Pharmaceuticals LLC Recent Developments
10.17 OASIS Medical
10.17.1 OASIS Medical Company Information, Head Office, Market Area, and Industry Position
10.17.2 OASIS Medical Pterygium Drug Models, Specifications, and Application
10.17.3 OASIS Medical Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.17.4 OASIS Medical Company Profile and Main Business
10.17.5 OASIS Medical Recent Developments
10.18 Similasan Corporation
10.18.1 Similasan Corporation Company Information, Head Office, Market Area, and Industry Position
10.18.2 Similasan Corporation Pterygium Drug Models, Specifications, and Application
10.18.3 Similasan Corporation Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.18.4 Similasan Corporation Company Profile and Main Business
10.18.5 Similasan Corporation Recent Developments
10.19 Alcon
10.19.1 Alcon Company Information, Head Office, Market Area, and Industry Position
10.19.2 Alcon Pterygium Drug Models, Specifications, and Application
10.19.3 Alcon Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.19.4 Alcon Company Profile and Main Business
10.19.5 Alcon Recent Developments
10.20 Santen Pharmaceutical
10.20.1 Santen Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.20.2 Santen Pharmaceutical Pterygium Drug Models, Specifications, and Application
10.20.3 Santen Pharmaceutical Pterygium Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.20.4 Santen Pharmaceutical Company Profile and Main Business
10.20.5 Santen Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Pterygium Drug Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Pterygium Drug Market Restraints
Table 3. Pterygium Drug Market Trends
Table 4. Pterygium Drug Industry Policy
Table 5. Global Pterygium Drug Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Pterygium Drug Revenue Share by Company, 2019-2024, Ranked by Data of 2024
Table 7. Global Pterygium Drug Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024
Table 8. Global Pterygium Drug Sales Quantity by Company, 2019-2024, Ranked by Data of 2024
Table 9. Global Pterygium Drug Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)
Table 10. Global Pterygium Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Pterygium Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Pterygium Drug Manufacturers Product Type
Table 13. Head Office and Pterygium Drug Production Site of Key Manufacturer
Table 14. Pterygium Drug Capacity of Major Manufacturers and Future Plan
Table 15. China Pterygium Drug Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024
Table 16. China Pterygium Drug Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024
Table 17. China Pterygium Drug Sales Quantity by Company, 2019-2024, Ranked by Data of 2024
Table 18. Global Pterygium Drug Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 19. Global Pterygium Drug Production by Region, 2019-2024, (K Units)
Table 20. Global Pterygium Drug Production Forecast by Region, 2024-2030, (K Units)
Table 21. Global Key Players of Pterygium Drug Upstream (Raw Materials)
Table 22. Global Pterygium Drug Typical Customers
Table 23. Pterygium Drug Typical Distributors
Table 24. By Type, Global Pterygium Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 25. By Application, Global Pterygium Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 26. By Region, Global Pterygium Drug Consumption Value, 2019 VS 2024 VS 2030, US$ Million
Table 27. By Region, Global Pterygium Drug Consumption Value, 2019-2030, US$ Million
Table 28. By Region, Global Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Table 29. By Country, Global Pterygium Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Country, Global Pterygium Drug Consumption Value, 2019-2030, US$ Million
Table 31. By Country, Global Pterygium Drug Consumption Value Market Share, 2019-2030
Table 32. By Country, Global Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Table 33. By Country, Global Pterygium Drug Sales Quantity Market Share, 2019-2030
Table 34. Johnson & Johnson Services, Inc Company Information, Head Office, Market Area, and Industry Position
Table 35. Johnson & Johnson Services, Inc Pterygium Drug Models, Specifications, and Application
Table 36. Johnson & Johnson Services, Inc Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 37. Johnson & Johnson Services, Inc Company Profile and Main Business
Table 38. Johnson & Johnson Services, Inc Recent Developments
Table 39. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 40. Novartis AG Pterygium Drug Models, Specifications, and Application
Table 41. Novartis AG Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Novartis AG Company Profile and Main Business
Table 43. Novartis AG Recent Developments
Table 44. Akorn Operating Company LLC Company Information, Head Office, Market Area, and Industry Position
Table 45. Akorn Operating Company LLC Pterygium Drug Models, Specifications, and Application
Table 46. Akorn Operating Company LLC Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Akorn Operating Company LLC Company Profile and Main Business
Table 48. Akorn Operating Company LLC Recent Developments
Table 49. Bausch & Lomb Incorporated Company Information, Head Office, Market Area, and Industry Position
Table 50. Bausch & Lomb Incorporated Pterygium Drug Models, Specifications, and Application
Table 51. Bausch & Lomb Incorporated Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Bausch & Lomb Incorporated Company Profile and Main Business
Table 53. Bausch & Lomb Incorporated Recent Developments
Table 54. AbbVie Inc Company Information, Head Office, Market Area, and Industry Position
Table 55. AbbVie Inc Pterygium Drug Models, Specifications, and Application
Table 56. AbbVie Inc Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. AbbVie Inc Company Profile and Main Business
Table 58. AbbVie Inc Recent Developments
Table 59. Prestige Consumer Healthcare Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Prestige Consumer Healthcare Inc Pterygium Drug Models, Specifications, and Application
Table 61. Prestige Consumer Healthcare Inc Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Prestige Consumer Healthcare Inc Company Profile and Main Business
Table 63. Prestige Consumer Healthcare Inc Recent Developments
Table 64. Spectra Vision Care Company Information, Head Office, Market Area, and Industry Position
Table 65. Spectra Vision Care Pterygium Drug Models, Specifications, and Application
Table 66. Spectra Vision Care Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Spectra Vision Care Company Profile and Main Business
Table 68. Spectra Vision Care Recent Developments
Table 69. Théa Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 70. Théa Laboratories Pterygium Drug Models, Specifications, and Application
Table 71. Théa Laboratories Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Théa Laboratories Company Profile and Main Business
Table 73. Théa Laboratories Recent Developments
Table 74. Wellona Pharma Company Information, Head Office, Market Area, and Industry Position
Table 75. Wellona Pharma Pterygium Drug Models, Specifications, and Application
Table 76. Wellona Pharma Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Wellona Pharma Company Profile and Main Business
Table 78. Wellona Pharma Recent Developments
Table 79. SAGER PHARMA Company Information, Head Office, Market Area, and Industry Position
Table 80. SAGER PHARMA Pterygium Drug Models, Specifications, and Application
Table 81. SAGER PHARMA Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. SAGER PHARMA Company Profile and Main Business
Table 83. SAGER PHARMA Recent Developments
Table 84. Maya Biotech Private Limited Company Information, Head Office, Market Area, and Industry Position
Table 85. Maya Biotech Private Limited Pterygium Drug Models, Specifications, and Application
Table 86. Maya Biotech Private Limited Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Maya Biotech Private Limited Company Profile and Main Business
Table 88. Maya Biotech Private Limited Recent Developments
Table 89. EYERIS VISIONCARE Pvt。Ltd Company Information, Head Office, Market Area, and Industry Position
Table 90. EYERIS VISIONCARE Pvt。Ltd Pterygium Drug Models, Specifications, and Application
Table 91. EYERIS VISIONCARE Pvt。Ltd Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. EYERIS VISIONCARE Pvt。Ltd Company Profile and Main Business
Table 93. EYERIS VISIONCARE Pvt。Ltd Recent Developments
Table 94. Sylentis Company Information, Head Office, Market Area, and Industry Position
Table 95. Sylentis Pterygium Drug Models, Specifications, and Application
Table 96. Sylentis Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Sylentis Company Profile and Main Business
Table 98. Sylentis Recent Developments
Table 99. Bayer AG Company Information, Head Office, Market Area, and Industry Position
Table 100. Bayer AG Pterygium Drug Models, Specifications, and Application
Table 101. Bayer AG Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Bayer AG Company Profile and Main Business
Table 103. Bayer AG Recent Developments
Table 104. Zydus Group Company Information, Head Office, Market Area, and Industry Position
Table 105. Zydus Group Pterygium Drug Models, Specifications, and Application
Table 106. Zydus Group Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. Zydus Group Company Profile and Main Business
Table 108. Zydus Group Recent Developments
Table 109. Amneal Pharmaceuticals LLC Company Information, Head Office, Market Area, and Industry Position
Table 110. Amneal Pharmaceuticals LLC Pterygium Drug Models, Specifications, and Application
Table 111. Amneal Pharmaceuticals LLC Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. Amneal Pharmaceuticals LLC Company Profile and Main Business
Table 113. Amneal Pharmaceuticals LLC Recent Developments
Table 114. OASIS Medical Company Information, Head Office, Market Area, and Industry Position
Table 115. OASIS Medical Pterygium Drug Models, Specifications, and Application
Table 116. OASIS Medical Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 117. OASIS Medical Company Profile and Main Business
Table 118. OASIS Medical Recent Developments
Table 119. Similasan Corporation Company Information, Head Office, Market Area, and Industry Position
Table 120. Similasan Corporation Pterygium Drug Models, Specifications, and Application
Table 121. Similasan Corporation Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 122. Similasan Corporation Company Profile and Main Business
Table 123. Similasan Corporation Recent Developments
Table 124. Alcon Company Information, Head Office, Market Area, and Industry Position
Table 125. Alcon Pterygium Drug Models, Specifications, and Application
Table 126. Alcon Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 127. Alcon Company Profile and Main Business
Table 128. Alcon Recent Developments
Table 129. Santen Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 130. Santen Pharmaceutical Pterygium Drug Models, Specifications, and Application
Table 131. Santen Pharmaceutical Pterygium Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 132. Santen Pharmaceutical Company Profile and Main Business
Table 133. Santen Pharmaceutical Recent Developments
List of Figures
Figure 1. Pterygium Drug Picture
Figure 2. Global Pterygium Drug Consumption Value, (US$ million) & (2019-2030)
Figure 3. Global Pterygium Drug Sales Quantity, (K Units) & (2019-2030)
Figure 4. Global Pterygium Drug Average Selling Price (ASP), (2019-2030) & (US$/Unit)
Figure 5. China Pterygium Drug Consumption Value, (US$ million) & (2019-2030)
Figure 6. China Pterygium Drug Sales Quantity (K Units) & (2019-2030)
Figure 7. China Pterygium Drug Average Selling Price (ASP), (US$/Unit) & (2019-2030)
Figure 8. By Consumption Value, China Pterygium Drug Market Share of Global, 2019-2030
Figure 9. By Sales Quantity, China Pterygium Drug Market Share of Global, 2019-2030
Figure 10. Global Pterygium Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 11. China Pterygium Drug Key Participants, Market Share, 2024
Figure 12. Global Pterygium Drug Capacity, Production and Capacity Utilization, 2019-2030
Figure 13. Global Pterygium Drug Capacity Market Share by Region, 2024 VS 2030
Figure 14. Global Pterygium Drug Production Market Share & Forecast by Region, 2019-2030
Figure 15. Pterygium Drug Industry Chain
Figure 16. Pterygium Drug Procurement Model
Figure 17. Pterygium Drug Sales Model
Figure 18. Pterygium Drug Sales Channels, Direct Sales, and Distribution
Figure 19. Artificial Tears
Figure 20. Steroid Eye Drops
Figure 21. Other
Figure 22. By Type, Global Pterygium Drug Consumption Value, 2019-2030, US$ Million
Figure 23. By Type, Global Pterygium Drug Consumption Value Market Share, 2019-2030
Figure 24. By Type, Global Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 25. By Type, Global Pterygium Drug Sales Quantity Market Share, 2019-2030
Figure 26. By Type, Global Pterygium Drug Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 27. Progressive Pterygium
Figure 28. Atrophic Pterygium
Figure 29. By Application, Global Pterygium Drug Consumption Value, 2019-2030, US$ Million
Figure 30. By Application, Global Pterygium Drug Consumption Value Market Share, 2019-2030
Figure 31. By Application, Global Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 32. By Application, Global Pterygium Drug Sales Quantity Market Share, 2019-2030
Figure 33. By Application, Global Pterygium Drug Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 34. By Region, Global Pterygium Drug Consumption Value Market Share, 2019-2030
Figure 35. By Region, Global Pterygium Drug Sales Quantity Market Share, 2019-2030
Figure 36. North America Pterygium Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 37. By Country, North America Pterygium Drug Consumption Value Market Share, 2024
Figure 38. Europe Pterygium Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 39. By Country, Europe Pterygium Drug Consumption Value Market Share, 2024
Figure 40. Asia Pacific Pterygium Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 41. By Country/Region, Asia Pacific Pterygium Drug Consumption Value Market Share, 2024
Figure 42. South America Pterygium Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, South America Pterygium Drug Consumption Value Market Share, 2024
Figure 44. Middle East & Africa Pterygium Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 45. U.S. Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 46. By Type, U.S. Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 47. By Application, U.S. Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 48. Europe Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 49. By Type, Europe Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 50. By Application, Europe Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 51. China Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 52. By Type, China Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 53. By Application, China Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 54. Japan Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 55. By Type, Japan Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 56. By Application, Japan Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 57. South Korea Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 58. By Type, South Korea Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 59. By Application, South Korea Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 60. Southeast Asia Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 61. By Type, Southeast Asia Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 62. By Application, Southeast Asia Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 63. India Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 64. By Type, India Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 65. By Application, India Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 66. Middle East & Africa Pterygium Drug Sales Quantity, 2019-2030, (K Units)
Figure 67. By Type, Middle East & Africa Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 68. By Application, Middle East & Africa Pterygium Drug Sales Quantity Market Share, 2024 VS 2030
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|